Juan Sanchez | VP, Corporate Communications & IR |
Sharon Mates | Co-Founder, Chairman, CEO & President |
Mark Neumann | EVP & Chief Commercial Officer |
Andrew Satlin | EVP & Chief Medical Officer |
Lawrence Hineline | SVP, Finance, CFO, Treasurer and Assistant Secretary |
Charles Duncan | Cantor Fitzgerald |
Jessica Fye | JPMorgan Chase & Co. |
Andrew Tsai | Jefferies |
Marc Goodman | SVB Leerink |
Owen Drinkwater | RBC Capital Markets |
Sumant Kulkarni | Canaccord Genuity |
Robert Hazlett | BTIG |
Good morning, ladies and gentlemen, and welcome to the Intra-Cellular Therapies Third Quarter ended September 30, 2019, Financial Results Conference Call. [Operator Instructions].
As a reminder, today's conference call is being recorded. I'd now like to turn the conference call over to your host, Dr. Juan Sanchez, Vice President, Corporate Communications and Investor Relations.